Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

Medicine, Oncology, Radiation Oncology +15

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Sandra Demaria, Bruce Ng, M. Devitt et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 1.4K citations

Medicine, Immunology, Oncology +16

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

Simon J. Dovedi, Amy L. Adlard, Grazyna Lipowska‐Bhalla et al. · Cancer Research · 2014 · 1.3K citations · Full text

Life Sciences, Immunology, Oncology +17

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

Walter J. Curran, Rebecca Paulus, Corey J. Langer et al. · JNCI Journal of the National Cancer Institute · 2011 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +13